Answers are grounded in this paper and cite their sources.
Dual contraception is crucial for preventing both unintended pregnancies and HIV/STIs, especially for women living with HIV. However, the impact of HIV status on dual contraception uptake is not well understood. This study assessed the association between HIV status and dual contraception use among women at Spilhaus Clinic. A cross-sectional pilot study recruited 80 women (18–49 years) seeking family planning services between January and April 2024. The mean age was 33.5 years, and 66.3% were married. Dual contraception prevalence was 31.2%, with male condoms and pills (54.8%) being the most common method. Women with HIV (83%) were significantly more likely to use dual contraception than HIV-negative women (27%; p = .01). Income level also influenced uptake (p = .004). Women with HIV had 3.09 times higher prevalence of use (p < .0001). Findings emphasize the need for targeted education and counseling on dual contraception, especially for high-risk groups.
No takes yet. Share an insight, caveat, or question.
Musvosvi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: